Leducq Foundation Leducq Foundation Leducq Foundation Leducq Foundation
  • About
    • Leducq Organization
    • History
    • Leadership
  • Networks of Excellence
    • How to Apply
    • Funded Networks
    • Policies & Documents
  • Rheumatic Heart Disease
    • Acute Rheumatic Fever Biomarker Project
    • Group A Strep – Immune Correlates of Protection
      • Application Instructions
      • Application Timetable 2022-2023
    • Group A Strep Vaccine Development
    • Polymeric Heart Valve
    • Policies & Documents
  • News
    • Latest Developments
    • Subscribe
  • Contact
    • Leducq Organization
Leducq Foundation Leducq Foundation
  • About
    • Leducq Organization
    • History
    • Leadership
  • Networks of Excellence
    • How to Apply
    • Funded Networks
    • Policies & Documents
  • Rheumatic Heart Disease
    • Acute Rheumatic Fever Biomarker Project
    • Group A Strep – Immune Correlates of Protection
      • Application Instructions
      • Application Timetable 2022-2023
    • Group A Strep Vaccine Development
    • Polymeric Heart Valve
    • Policies & Documents
  • News
    • Latest Developments
    • Subscribe
  • Contact
    • Leducq Organization

2024

Leducq Foundation

Immune targets for the treatment of atrial fibrillation | 2024

Though atrial fibrillation (AFib) is the most common arrhythmia and frequently leads to stroke, heart failure and increased mortality, current anti-arrhythmic drug treatment has limited efficacy. We propose to address... read more →
  • June 11, 2024
  • Jake Powers

Calcification-Omics, Molecular Elucidation, & Therapeutics (COMET) | 2024

Vascular calcification is a global health burden contributing to a multitude of cardiovascular diseases including atherosclerotic cardiovascular disease, arterial stiffness with associated hypertensive heart disease, and small vessel disease such... read more →
  • June 11, 2024
  • Jake Powers

PRIORITY: cardio-laminoPathy: fRom pathomechanIsms tO peRsonalIzed TherapY | 2024

LMNA-related dilated cardiomyopathy (LMNA-DCM) is a severe and inherited disease caused by mutations in the LMNA gene. This gene provides instructions for making proteins called A-type Lamins (Lamins A/C), which... read more →
  • June 11, 2024
  • Jake Powers

The Placenta in Maternal and Fetal Cardiovascular Health and Disease | 2024

The placenta is at the epicenter of maternal and fetal health. It is a large, highly vascular, and highly hormonal organ that both sustains fetal development and simultaneously reprograms maternal... read more →
  • June 11, 2024
  • Jake Powers

SUBSCRIBE

Please join our mailing list to receive information regarding grant information, research highlights, and more.

Subscribe Now

CONTACT

BOSTON

265 Franklin Street, Suite 1902
Boston, Massachusetts 02110

PHONE: +1 617.459.4688
EMAIL: contact@flcq.org

Contact Us
© 2005-[Y] The Leducq Foundation. All Rights Reserved. Home | Contact | Sitemap | Privacy Policy